/

Azenta, Inc.

AZTA US

AZTA USAzenta, Inc.

United States Composite

52.04

USD

-0.08

(-0.15%)

-0.30EPS Dil.

-172.66P/E

2.90BMarket Cap

Next Earnings

May 7

Ex-Dividend Date

December 2

Dividend Date

December 23

Held by Insiders

1.90%

Held by Institutions

105.74%

Short % of Float

7.37%

YTD Yield

22.46%

3Y Yield

-48.50%

5Y Yield

37.86%

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'24

ST Debt

- -

LT Borrowings

- -

LT Finance Leases

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

2,857

2,903

3,629

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'24

Total Current Assets

1,511

1,419

1,383

Cash, Cash Equivalents & STI

1,124

1,018

984

Accounts Receivable, Net

163

157

156

Inventories

142

128

127

Total Current Liabilities

204

211

236

Payables & Accruals

125

144

ST Debt

- -

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

7.80%

5.85%

19.82%

Net Income, GAAP

-42.32%

396.02%

-100.66%

Free Cash Flow

-547.72%

-1,121.40%

95.95%

Total Cash Common Dividend

- -

Total Equity

21.89%

40.71%

-24.62%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2022

140

146

133

138

555

2023

178

148

166

172

665

2024

154

- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2022

0.58

28.28

-0.13

-0.28

28.48

2023

-0.15

-0.07

-0.02

0.06

-0.22

2024

-0.28

- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2022

0.10

- -

0.10

2023

- -

2024

- -

Company Description

CEO: Dr. Stephen S. Schwartz
Full Time Employees: 3,500
Sector: Healthcare
Industry: Medical Instruments & Supplies
Address: 200 Summit Drive Burlington MA United States 01803
CIK: 0000933974
Website: www.azenta.com
Business: Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Company News

Yahoo
23 days ago
Azenta, Inc. (NASDAQ:AZTA) Shares Could Be 35% Above Their Intrinsic Value Estimate
Tipranks
24 days ago
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
Tipranks
a month ago
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
Yahoo
a month ago
Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report
Yahoo
a month ago
Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Tipranks
a month ago
Buy Rating Affirmed for Azenta: A Promising Future Backed by Strategic Growth Plans
Reuters
a month ago
Nvidia's dizzying rally spurs rush into AI-themed ETFs
Tipranks
2 months ago
Azenta: A Strong Buy on Robust Financial Guidance and Market-Leading Position
Yahoo
2 months ago
Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
Tipranks
2 months ago
Buy Rating Affirmed: Azenta’s Strong Financial Outlook and Strategic Growth Trajectory

Company Description

CEO: Dr. Stephen S. Schwartz
Full Time Employees: 3,500
Sector: Healthcare
Industry: Medical Instruments & Supplies
Address: 200 Summit Drive Burlington MA United States 01803
CIK: 0000933974
Website: www.azenta.com
Business: Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Company News

Yahoo
23 days ago
Azenta, Inc. (NASDAQ:AZTA) Shares Could Be 35% Above Their Intrinsic Value Estimate
Tipranks
24 days ago
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
Tipranks
a month ago
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)
Yahoo
a month ago
Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report
Yahoo
a month ago
Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Tipranks
a month ago
Buy Rating Affirmed for Azenta: A Promising Future Backed by Strategic Growth Plans
Reuters
a month ago
Nvidia's dizzying rally spurs rush into AI-themed ETFs
Tipranks
2 months ago
Azenta: A Strong Buy on Robust Financial Guidance and Market-Leading Position
Yahoo
2 months ago
Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
Tipranks
2 months ago
Buy Rating Affirmed: Azenta’s Strong Financial Outlook and Strategic Growth Trajectory